News
Trading Update - Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded
News
Hikma launches first prefilled syringe of Succinylcholine Chloride Injection, USP
News
Hikma announces the appointment of Deneen Vojta, M.D. as an independent Non-Executive Director, effective 1 November 2022
Find out more
Our Injectables manufacturing and supply in North America, Europe and MENA
Investor insight
Read here, the reasons to invest in Hikma
Investor insight
Listen to our audio webcast with Khalid Nabilsi, CFO & Riad Mishlawi, President, Injectables available until 14 February 2023
#OwnYourCareer @Hikma
Meet Thomas Manhart, Customer Service Officer - Injectables, Germany site and discover why he loves working at Hikma!
#OwnYourCareer @Hikma
Meet Selmoune Imane, Medical Representative, Algeria site and discover why she loves working at Hikma!
Find out more
Minimising our impact on the environment.
Careers
Join us in helping to put better health within reach for millions of people
Find out more
Our 2021 Sustainability Report
Find out more
Our 2021 Annual Report